News Illumina says Icahn’s board candidates “do not add value” Icahn's board picks "will damage Illumina’s core business," says the gene sequencing company.
News Chasing BMS, Takeda trumpets TYK2 data in psoriasis Pharma group is hoping for big things, after splashing out $4bn upfront for the drug last year.
News Digital health firm Pear considers future as cash dwindles Company looks at possible sale, merger or licensing deal after making big layoffs last year.
News Sanofi cuts price of Lantus insulin in US by 78% Pharma joins Eli Lilly, Novo Nordisk as it slashes the price of its widely-prescribed insulins.
News Esperion and Daiichi Sankyo square up on Nexletol milestone Companies can't see eye to eye on the recently reported data from the CLEAR outcomes study.
News Novo Nordisk suspended from ABPI after code breach The two-year ban reflects "serious breaches” of the trade organisation’s code of practice.
News Rezzayo antifungal okayed as Candida auris rings alarm bells Drug is first new echinocandin to be approved for marketing in the US in more than a decade.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
